Date: 2023-01-05Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 227/2019 of 27 September 2019 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/32]
## Policy Summary: EEA Joint Committee Decision No. 227/2019
This decision, enacted by the EEA Joint Committee on September 27, 2019, amends Annex II (Technical regulations, standards, testing and certification) to the Agreement on the European Economic Area (EEA). The amendment incorporates two key Commission Implementing acts into the EEA Agreement:
1. **Commission Implementing Regulation (EU) 2019/637:** This regulation approves cholecalciferol as an active substance for use in biocidal products of product-type 14. (OJ L 109, 24.4.2019, p. 13)
2. **Commission Implementing Decision (EU) 2019/641:** This decision concerns the terms and conditions for the authorization of a biocidal product family containing 1R-trans phenothrin, as referred by Ireland under Article 36 of Regulation (EU) No 528/2012. (OJ L 109, 24.4.2019, p. 26)
The decision stipulates that the Icelandic and Norwegian language versions of Implementing Regulation (EU) 2019/637 and Implementing Decision (EU) 2019/641 will be published in the EEA Supplement to the Official Journal of the European Union and will be considered authentic.
This Decision entered into force on September 28, 2019, following the completion of all notifications required under Article 103(1) of the EEA Agreement. The decision was published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Key Entities Referenced
EEA Joint Committee: The decision-making body responsible for the management of the Agreement on the European Economic Area (EEA).
EEA Agreement: The Agreement on the European Economic Area, which extends the European Union's single market to Iceland, Liechtenstein, and Norway.
Commission Implementing Regulation EU 2019/637: A European Union regulation approving cholecalciferol as an active substance for use in biocidal products of product-type 14.
Commission Implementing Decision EU 2019/641: A European Union decision on the terms and conditions of the authorisation of a biocidal product family containing 1R-trans phenothrin referred by Ireland.
Regulation EU No 528/2012: A European Union regulation of the European Parliament and of the Council concerning the making available on the market and use of biocidal products.
Iceland: A Nordic island country in the North Atlantic.
Norway: A Nordic country in Northern Europe, whose mainland territory comprises the western and northernmost portion of the Scandinavian Peninsula.
Brussels: The capital of Belgium and a major center for European politics and administration.
L 4/42 EN Official Journal of the European Union 5.1.2023
DECISION OF THE EEA JOINT COMMITTEE No 227/2019
of 27 September 2019
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
[2023/32]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2019/637 of 23 April 2019 approving cholecalciferol as an active
substance for use in biocidal products of product-type 14(1)is to be incorporated into the EEA Agreement.
(2) Commission Implementing Decision (EU) 2019/641 of 17 April 2019 on the terms and conditions of the
authorisation of a biocidal product family containing 1R-trans phenothrin referred by Ireland in accordance with
Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council(2)is to be incorporated
into the EEA Agreement.
(3) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following points are inserted after point 12zzzzzw (Commission Implementing Decision (EU) 2018/1251) of Chapter
XV of Annex II to the EEA Agreement:
‘12zzzzzx. 32019 R 0637: Commission Implementing Regulation (EU) 2019/637 of 23 April 2019 approving
cholecalciferol as an active substance for use in biocidal products of product-type 14 (OJ L 109, 24.4.2019,
p. 13).
12zzzzzy. 32019 D 0641: Commission Implementing Decision (EU) 2019/641 of 17 April 2019 on the terms and
conditions of the authorisation of a biocidal product family containing 1R-trans phenothrin referred by
Ireland in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the
Council (OJ L 109, 24.4.2019, p. 26).’
Article 2
The texts of Implementing Regulation (EU) 2019/637 and Implementing Decision (EU) 2019/641 in the Icelandic and
Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 28 September 2019, provided that all the notifications under Article 103(1) of the
EEA Agreement have been made(*).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
(1) OJ L 109, 24.4.2019, p. 13.
(2) OJ L 109, 24.4.2019, p. 26.
(*) No constitutional requirements indicated.5.1.2023 EN Official Journal of the European Union L 4/43
Done at Brussels, 27 September 2019.
For the EEA Joint Committee
The President
Gunnar PÁLSSON